Authors: | Davis, B. E.; Herr, H. W.; Fair, W. R.; Bosl, G. J. |
Article Title: | The management of patients with nonseminomatous germ cell tumors of the testis with serologic disease only after orchiectomy |
Abstract: | Management of patients with nonseminomatous germ cell tumors of the testis who have persistently elevated serum tumor marker levels (α-fetoprotein and/or human chorionic gonadotropin) following orchiectomy and no clinical evidence of disease is controversial. We reviewed our experience with 15 such patients at our cancer center between March 1977 and November 1991. Group 1 (11 patients) underwent initial retroperitoneal lymph node dissection and group 2 (4 patients) received primary chemotherapy. All group 1 patients required subsequent chemotherapy for retroperitoneal disease or persistent marker elevation, whereas only 1 of the 4 who received primary chemotherapy required later surgery. We conclude that tumor marker elevation in this setting is usually indicative of systemic tumor, which is best treated primarily by initial chemotherapy. |
Keywords: | adolescent; adult; cancer chemotherapy; cancer survival; clinical article; survival rate; cisplatin; doxorubicin; conference paper; lymph node dissection; lymph node excision; computer assisted tomography; etoposide; cyclophosphamide; tumor marker; vinblastine; diagnosis; testis tumor; testicular neoplasms; patient compliance; dactinomycin; bleomycin; lactate dehydrogenase; orchiectomy; drug therapy; germ cell tumor; testis; chlorambucil; bone scintiscanning; retroperitoneal cancer; alpha fetoprotein; chorionic gonadotropin; lymphangiography; intravenous urography; human; male; priority journal |
Journal Title: | Journal of Urology |
Volume: | 152 |
Issue: | 1 |
ISSN: | 0022-5347 |
Publisher: | Elsevier Science, Inc. |
Date Published: | 1994-07-01 |
Start Page: | 111 |
End Page: | 113; discussion 114 |
Language: | English |
PUBMED: | 7515445 |
PROVIDER: | scopus |
DOI: | 10.1016/s0022-5347(17)32830-6 |
DOI/URL: | |
Notes: | Source: Scopus |